Skip to main content
. 2023 Feb 25;14(2):159. doi: 10.1038/s41419-023-05696-1

Table 2.

Univariate and multivariate analyses of risk factors for disease-free survival of prostate cancer.

Variable Univariate analysis HR (95% CI) P value Multivariate analysis HR (95% CI) P value
NRP1 (high/low) 1.65 (1.21–2.23) 0.001 1.45 (1.02–2.06) 0.037
Gleason score (>8/<=8) 2.83 (2.04–3.92) <0.001 1.86 (1.21–2.85) 0.0046
Age (>65/<=65) 1.12 (0.81–1.54) 0.51 NA NA
PSA (<=10/>10) 2.64 (1.39–5.03) 0.003 0.89 (0.43–1.88) 0.78
Stage (T4/T3/T2) 2.62 (1.74–3.95) <0.001 1.07 (0.59–1.95) 0.82
Lymphatic metastasis (yes/no) 1.49 (1.06–2.11) 0.02 0.90 (0.61–1.32) 0.58
Surgical margin (positive/negative) 1.78 (1.33–2.39) <0.001 1.60 (1.12–2.29) 0.01
Biochemical recurrence (yes/no) 4.56 (3.37–6.15) <0.001 2.96 (2.07–4.24) <0.001